Sanford Glenn Darrel

EXPI CEO Sanford Glenn Darrel sold 50,000 shares at $12.60 on 2024-12-17; stock now $11.63, down 29.7% from 52-week high.

CEO Sanford Glenn Darrel sold 50,000 shares at $12.60, reducing his stake from 40.26M to 40.21M shares (-0.1%). The transaction occurred when EXPI stock was already 29.7% below its 52-week high and has declined 7.0% in the 30 days since. EXP World Holdings reported negative net income of $-8,506,000 in its latest quarter against revenue of $1,231,187,000, with annual revenue contraction of 6.9% year-over-year. In his same-ticker history at EXPI, Darrel executed five consecutive sells over the prior six weeks (2024-11-12 through 2024-12-17); the two measurable 30-day outcomes (-11.0% and -8.5%) moved unfavorably after sale. This sustained sequence of sales into a declining stock price warrants examination of the company's near-term operating trajectory.

CEO Sanford Glenn Darrel sold 50,000 shares of EXPI at $13.00 on 2024-12-10; stock down -22.2% from 52-week high, company unprofitable.

Sanford Glenn Darrel, as CEO and Chairman, sold 50,000 shares at $13.00 on 2024-12-10, reducing holdings from 40,309,080 to 40,259,080 shares. This sale occurs in a context of significant stock price weakness: EXPI has declined -11.9% over 30 days and -22.2% from its 52-week high of $16.54, while the company reported a net loss of $-8.5M on quarterly revenue of $1.2B and negative full-year net income. The broader pattern warrants attention—this is the fifth EXPI sale in the past month (prior sales on 2024-11-05, 11-12, 11-18, 11-25, and 12-03), suggesting sustained selling pressure from the top executive. Across his cross-ticker history, Darrel's 20 prior sales showed a 0.00% well-timed rate at the 90-day mark, and his same-ticker sales at EXPI have not yet demonstrated measurable 90-day outcomes.

CEO Glenn Sanford sold 49,881 shares of EXPI at $13.87 on 2024-12-03, worth $691,794.60 (0.1% of holdings)

CEO and Chairman Sanford Glenn Darrel sold 49,881 shares at $13.87, reducing his stake from 40,389,080 to 40,339,199 shares. The transaction occurred amid recent consecutive daily sales at EXPI (five sells between 2024-11-05 and 2024-11-25), yet the stock has posted +4.4% returns over the past 30 days and +18.8% over 90 days, suggesting any prior sales have not preceded material declines. Cross-ticker, the insider's 20 prior sells averaged +4.0% returns at 30 days and +9.1% at 90 days with 0.00% well-timed rate—indicating historically weak sell-timing accuracy. Against a backdrop of company fundamentals showing a $-8.5M net loss over the most recent full year and -6.9% annual revenue decline, the CEO's incremental disposals warrant monitoring, though the modest sale size (0.1% of holdings) and persistence of share ownership across 40.34M shares suggest no urgent exit posture.

CEO Sanford Glenn Darrel sold 50,000 shares of EXPI at $14.41 on 2024-11-25; stock now $14.38. Unprofitable fundamentals (-$8.5M net income) amid pattern of frequent recent sales.

CEO Sanford Glenn Darrel sold 50,000 shares at $14.41, representing only 0.1% of his 40.44M pre-transaction holdings. The sale occurred within an accelerated selling pattern: this trade is the sixth insider sale at EXPI in three weeks (five prior sales between 2024-10-29 and 2024-11-18). The company remains unprofitable with negative $8.5M net income in the latest quarter, revenue declining -6.9% year-over-year, and the stock trading -13.1% below its 52-week high despite a recent 30-day rebound of +12.2%. His cross-ticker track record shows 20 prior sells with poor timing outcomes (0.00% well-timed rate at the 90-day mark), providing no evidence of predictive skill for this transaction. The rapid sequence of sales from the CEO, combined with deteriorating financial results, warrants investor attention to underlying business momentum and capital allocation priorities.

CEO Glenn Darrel sold 50.0K shares at $12.72 on 2024-11-18; stock -24.4% from 52-week high.

Sanford Glenn Darrel, CEO and Chairman, sold 50,000 shares of EXPI at $12.72, reducing his holdings by only 0.1% to 40.44M shares. The sale occurred as the stock trades -24.4% from its 52-week high of $16.54, and EXPI is operating unprofitably with a -6.9% revenue decline year-over-year. Darrel's five prior trades at EXPI (all sells occurring between 2024-10-22 and 2024-11-12) all have outcomes not yet measurable at the 90-day mark, so no pattern of timing accuracy at this ticker can be assessed. His cross-ticker track record shows prior sells were well-timed at a 25.00% rate over 20 open-market transactions, though the current stock price of $12.51 sits below the sale price, reflecting near-term downward pressure.

CEO Glenn Sanford sold 50,000 shares of EXPI at $14.48; stock now at $13.92, down from $16.54 52-week high. Company unprofitable with -6.9% revenue decline.

CEO and Chairman Sanford Glenn Darrel sold 50,000 shares at $14.48 on 2024-11-12, representing a 0.1% reduction in his 40.49M share position post-transaction. The sale occurred near the high end of the stock's 52-week range ($9.24–$16.54), with the stock now at $13.92. This follows a pattern of recent EXPI sales (five prior trades between 2024-10-15 and 2024-11-05) by the same insider. Company fundamentals show ongoing pressure: unprofitable in the most recent full fiscal year with net income of -$8.5M, and annual revenue declined 6.9% year-over-year despite latest quarterly revenue of $1.2B. The CEO's sustained selling activity over consecutive weeks, coupled with deteriorating profitability and declining revenue growth, warrants investor attention to underlying business momentum.

CEO Darrel sells 50,000 EXPI shares for $705,463.51; 5 sales in 5 weeks amid 30-day +8.7% rally and -6.9% annual revenue decline

Sanford Glenn Darrel, CEO and Chairman, executed 2 separate sales totaling 50,000 shares for $705,463.51 on 2024-11-05 at blended average price $14.11. This sale follows a rapid pattern: he has sold shares on five consecutive Tuesdays at EXPI (2024-10-01, 2024-10-08, 2024-10-15, 2024-10-22, 2024-10-29), with the current filing extending into November. The timing comes after the stock recovered +8.7% over the prior 30 days but remains -13.1% below its 52-week high of $16.54. Against this, the company faces structural headwinds: annual revenue declined -6.9% year-over-year, the company posted negative net income over its most recent full fiscal year, and the CEO has not demonstrated well-timed selling at EXPI (0 of 0 prior same-ticker sells were well-timed at the 90-day mark). The regular weekly cadence of sales—particularly five within a month—suggests a systematic execution pattern rather than a discretionary decision at a single moment.

EXPI CEO Sanford Glenn Darrel sold 40,000 shares at $12.88 (Oct 29), latest in pattern of weekly sales amid stock down 22.6% from 52-week high.

CEO Sanford Glenn Darrel executed his fifth sale in as many weeks, selling 40,000 shares on 2024-10-29 at $12.88, with four prior dispositions on 2024-10-22, 2024-10-15, 2024-10-08, and 2024-10-01. The stock has declined 22.6% from its 52-week high and remains down 9.2% over the past 30 days. While his cross-ticker track record shows a 100.00% well-timed rate on 20 prior sells with an average 90-day return of -7.2%, the same-ticker history at EXPI provides no measurable 90-day outcomes yet (only one sale from 2024-09-24 showed -10.1% at 30 days). The company posted negative full-year net income and reported annual revenue decline of -6.9%, creating a backdrop of operational headwinds. The consistent weekly cadence of dispositions, combined with stock weakness and deteriorating fundamentals, warrants observation of the company's earnings trajectory and whether the sell pattern continues.

CEO Sanford Glenn Darrel sold 40,000 shares of EXPI at $12.82 on 2024-10-22, maintaining a 40.63M share position in a company trading -22.7% from 52-week high.

Sanford Glenn Darrel, CEO and Chairman, sold 40,000 shares (worth $512,884.00) at $12.82 on 2024-10-22, reducing holdings by only -0.1%. The company faces headwinds: annual revenue declined -6.9%, full-year net income was negative, and the stock has fallen -9.5% in the past 30 days and -9.4% in the past 90 days, trading -22.7% below its 52-week high of $16.54. This represents the fourth consecutive weekly sale by the insider at EXPI (after sells on 2024-10-15, 2024-10-08, and 2024-10-01), suggesting a pattern of regular liquidation rather than a singular transaction. The cross-ticker track record shows the insider has executed 20 prior sells with an 80.00% well-timed rate at the 90-day mark, but at this specific ticker, prior trades remain in early measurement windows or have not yet demonstrated positive outcomes.

EXPI CEO Sanford Glenn Darrel sold 40,000 shares at $13.28 on 2024-10-15; stock now $13.15, -20.5% from 52-week high.

Sanford Glenn Darrel, CEO and Chairman, sold 40,000 shares at $13.28 on 2024-10-15, reducing his holdings from 40.71M to 40.67M shares (a -0.1% reduction). The sale occurs against a backdrop of significant downward price action: the stock has declined -7.9% over 30 days and -8.9% over 90 days from the transaction date, and is currently trading at $13.15, a -20.5% drawdown from its 52-week high of $16.54. Fundamentally, the company reported a full-year net loss, though posted $1.3B in latest-quarter revenue; annual revenue contracted -6.9% year-over-year. This transaction follows a rapid sequence of sales at the same ticker: four other sells occurred within the 17 days prior (Sept 17, Sept 18, Sept 24, Oct 1, Oct 8), suggesting sustained capital reduction activity by the CEO. The lack of measurable outcomes on those prior trades and the absence of a positive timing pattern at this ticker make it difficult to assess whether the CEO's recent selling reflects operational concern or routine portfolio management.